Asian Spectator

Men's Weekly

.

Singapore's first clinical trial approval for T cell engineere...

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
SINGAPORE, Aug. 20, 2018 /PRNewswire-AsiaNet/ -- Lion TCR Pte. Ltd., a Singapore-based Biotech company receives approval from Health Sciences Authority (HSA), Singapore, for its Phase I/II multicentre clinical study of its product candidate (LioCyx(TM)) for treatment of relapsed liver cancer pos...

Read more http://asianetnews.net/view-release?pr-id=74802

Magazine

Female genital cutting: why Southeast Asia should follow Africa’s lead in challenging religious and cultural justifications

Illustration of campaign against Female Genital Mutilation (FGM).Tunatura/ShutterstockFemale genital mutilation or cutting (FGM/C) remains a threat to the rights of women in Southeast Asia, often reli...

Manfaat tempe juga bisa menyehatkan tulang: Mengapa pengakuan dari UNESCO saja tidak cukup?

● Sejumlah negara (seperti Belgia dan Jepang) merekomendasikan warganya memperbanyak konsumsi tempe. ● Tempe punya banyak manfaat kesehatan, termasuk bagi kesehatan tulang.● Pemerint...

Pemberdayaan warga jadi solusi efektif meredam abrasi: Pelajaran dari pesisir Bulukumba

● Indonesia memiliki banyak kawasan pesisir rawan abrasi ekstrem, seperti di Bulukumba, Sulawesi Selatan.● Pemberdayaan masyarakat setempat amat krusial untuk mencegah abrasi.● Pemba...